Corona Updates You Must Track: With A Record 95,735 Cases In A Day, India COVID-19 Tally At 44.65 Lakh

Both Delhi and Mumbai reported the biggest surges in daily cases of coronavirus on Wednesday. Meanwhile, the Drug Controller General of India has issued a notice to Serum Institute

offline
Both Delhi and Mumbai reported the biggest surges in daily cases of coronavirus on Wednesday. Meanwhile, the Drug Controller General of India has issued a notice to Serum Institute

India cases and toll: In a record surge in daily cases, India reported 95,735 cases of coronavirus on Wednesday. With this, India’s COVID-19 case count has climbed to 44,65,863, as per the data shared by the Ministry of Health and Family Welfare. A total of 1,172 people succumbed to the disease in the last 24 hours—the coronavirus toll now stands at 75,062.

The active caseload has crossed the 9-lakh mark. India currently has 9,19,018 active cases of coronavirus while 34,71,783 people have recovered from the illness. India carried out 11,29,756 tests for COVID-19 on Wednesday.

Delhi COVID-19 count breaches 2-lakh mark: As the number of infections continues to surge in Delhi, the national capital’s overall COVID-19 caseload breached the 2-lakh mark on Wednesday. With 4,039 fresh cases on Wednesday, Delhi recorded its highest spike in daily cases; the coronavirus tally rose to 2,01,174.

The national capital currently has 23,773 active cases while 1,72,763 people have recovered from the illness. Delhi’s COVID-19 toll has reached 4,638 with 20 deaths reported in the last 24 hours.   

Serum Institute gets notice from drug regulator: Pune-based Serum Institute of India has been issued a notice by the Drug Controller General of India (DCGI) for not informing it about AstraZeneca halting the global trials of the experimental vaccine developed in association with the Oxford University and the suspected adverse effects reported in a patient. Serum Institute has partnered with the British-Swedish firm AstraZeneca to manufacture the COVID-19 vaccine, if successful, for low- and middle-income countries.

Read more!